Drug class
Mucolytic; secretolytic and mucokinetic agent (bromhexine metabolite)
Mechanism of action
The precise mechanism is not fully elucidated. Ambroxol increases serous respiratory secretion, stimulates ciliary activity and mucociliary clearance, and activates pulmonary surfactant production, helping reduce mucus viscosity and facilitate expectoration.
General use cases
- Expectorant use in acute and chronic respiratory conditions with abnormal viscid mucus, where authorised
- Lozenge formulations may be used for sore throat; injectable uses and indications differ by product and jurisdiction
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
